Page last updated: 2024-09-04

olmesartan and naloxone

olmesartan has been researched along with naloxone in 2 studies

Compound Research Comparison

Studies (olmesartan)	Trials (olmesartan)	Recent Studies (post-2010) (olmesartan)	Studies (naloxone)	Trials (naloxone)	Recent Studies (post-2010) (naloxone)
841	185	554	20,134	1,257	3,321

Protein Interaction Comparison

Protein	Taxonomy	naloxone (IC50)
Cytochrome P450 2D6	Homo sapiens (human)	2
Delta-type opioid receptor	Mus musculus (house mouse)	0.043
Delta-type opioid receptor	Rattus norvegicus (Norway rat)	0.0219
Mu-type opioid receptor	Rattus norvegicus (Norway rat)	0.0019
Kappa-type opioid receptor	Rattus norvegicus (Norway rat)	0.0019
Mu-type opioid receptor	Homo sapiens (human)	0.0397
Delta-type opioid receptor	Homo sapiens (human)	0.1896
Kappa-type opioid receptor	Cavia porcellus (domestic guinea pig)	0.05
Kappa-type opioid receptor	Homo sapiens (human)	0.0795
Mu-type opioid receptor	Mus musculus (house mouse)	0.0154
Mu-type opioid receptor	Cavia porcellus (domestic guinea pig)	0.0089
Beta-2 adrenergic receptor	Cavia porcellus (domestic guinea pig)	0.0055

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1

Other Studies

2 other study(ies) available for olmesartan and naloxone

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013

Article

Year

Hologram QSAR model for the prediction of human oral bioavailability.

Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007

Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.

Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013